Kestra Advisory Services’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.76M | Buy |
45,832
+11,636
| +34% | +$447K | 0.01% | 1139 |
|
|
2025
Q1 | $1.32M | Sell |
34,196
-13,391
| -28% | -$519K | 0.01% | 1213 |
|
|
2024
Q4 | $1.61M | Sell |
47,587
-114,849
| -71% | -$3.88M | 0.01% | 1116 |
|
|
2024
Q3 | $6.64M | Sell |
162,436
-16,846
| -9% | -$689K | 0.04% | 498 |
|
|
2024
Q2 | $6.9M | Buy |
179,282
+116,647
| +186% | +$4.49M | 0.04% | 483 |
|
|
2024
Q1 | $2.69M | Buy |
62,635
+22,551
| +56% | +$967K | 0.02% | 761 |
|
|
2023
Q4 | $1.49M | Sell |
40,084
-14,905
| -27% | -$552K | 0.01% | 945 |
|
|
2023
Q3 | $1.99M | Sell |
54,989
-1,317
| -2% | -$47.7K | 0.02% | 684 |
|
|
2023
Q2 | $2.01M | Buy |
56,306
+5,248
| +10% | +$187K | 0.02% | 671 |
|
|
2023
Q1 | $1.82M | Sell |
51,058
-15,102
| -23% | -$537K | 0.02% | 686 |
|
|
2022
Q4 | $2.32M | Sell |
66,160
-3,614
| -5% | -$127K | 0.02% | 687 |
|
|
2022
Q3 | $2.05M | Buy |
69,774
+5,507
| +9% | +$162K | 0.02% | 656 |
|
|
2022
Q2 | $3.5M | Buy |
64,267
+6,549
| +11% | +$356K | 0.04% | 470 |
|
|
2022
Q1 | $3.14M | Sell |
57,718
-1,024
| -2% | -$55.8K | 0.03% | 523 |
|
|
2021
Q4 | $3.24M | Sell |
58,742
-30,326
| -34% | -$1.67M | 0.03% | 516 |
|
|
2021
Q3 | $4.25M | Buy |
89,068
+12,342
| +16% | +$589K | 0.04% | 444 |
|
|
2021
Q2 | $3.82M | Buy |
76,726
+315
| +0.4% | +$15.7K | 0.04% | 432 |
|
|
2021
Q1 | $3.41M | Sell |
76,411
-46,997
| -38% | -$2.1M | 0.04% | 429 |
|
|
2020
Q4 | $5.71M | Buy |
123,408
+52,840
| +75% | +$2.45M | 0.07% | 300 |
|
|
2020
Q3 | $3.32M | Buy |
+70,568
| New | +$3.32M | 0.06% | 313 |
|